Tang Capital Management LLC Eli Lilly & CO Transaction History

Tang Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $1.78 Million - $2.38 Million	-3,000 Reduced 10.0%	27,000 $21 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $3.11 Million - $3.65 Million	10,000 Added 50.0%	30,000 $10.3 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $6.43 Million - $7.49 Million	20,000 New	20,000 $7.32 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tang Capital Management LLC with notifications on news.